Clonidine treatment of Gilles de la Tourette's syndrome.
about
Neuropsychiatric consequences of cardiovascular medicationsPharmacotherapy of aggression in children and adolescents: efficacy and effect sizeGilles de la Tourette's syndrome and its impact in the UKCommon factors among Alzheimer's disease, Parkinson's disease, and epilepsy: possible role of the noradrenergic nervous systemPsychopharmacology of Tic DisordersEuropean clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatmentAnimal models of tic disorders: a translational perspective.Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome.Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating.Assessing the validity of current mouse genetic models of obsessive-compulsive disorder.Alpha-2 agonists in the treatment of attention deficit hyperactivity disorder.Levetiracetam as an alternative therapy for Tourette syndrome.Gilles de la Tourette syndrome: symptomatic treatment based on evidence.Pharmacotherapy of disorders in mental retardation.Tourette's syndrome: are stimulants safe?Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy.Emerging drugs in Tourette syndrome.Practitioner Review: Treatments for Tourette syndrome in children and young people - a systematic review.The treatment of tics.Slitrks as emerging candidate genes involved in neuropsychiatric disordersThe obsessive-compulsive spectrums.Tourette's Syndrome in Children.Pediatric psychopharmacotherapy: a review of recent research.The role of the autonomic nervous system in Tourette SyndromeClinical Correlates and Mediators of Self-Concept in Youth with Chronic Tic DisordersTic disorders: from pathophysiology to treatment.Systematic review: pharmacological treatment of tic disorders--efficacy of antipsychotic and alpha-2 adrenergic agonist agents.Frontal-subcortical circuitry and behavior.Beyond methylphenidate: nonstimulant medications for youth with ADHD.Guanfacine and guanfacine extended release: treatment for ADHD and related disorders.Where does obsessive-compulsive disorder belong in DSM-V?The Efficacy and Tolerability of the Clonidine Transdermal Patch in the Treatment for Children with Tic Disorders: A Prospective, Open, Single-Group, Self-Controlled Study.A neurochemical yin and yang: does serotonin activate and norepinephrine deactivate the prefrontal cortex?Tourette syndrome and tic disorders: overview and practical guide to diagnosis and treatmentTreatment strategies for tics in Tourette syndrome.Aripiprazole for the treatment of adolescent Tourette's syndrome: a case report.What patients with gilles de la tourette syndrome should be treated with deep brain stimulation and what is the best target?The biochemistry of Tourette's syndrome.Contemporary approaches to pharmacotherapy in Tourette's syndrome and obsessive-compulsive disorder.Nonstimulant medications in the treatment of attention deficit hyperactivity disorder.
P2860
Q24635624-8A093D6B-8599-45CD-AF4D-F42C0D181111Q24648097-3EE3BB9A-F715-47AE-9D61-BACB2CC21B9CQ24680240-A1084283-9768-4ED6-93EE-235F672AEE43Q27010627-A5B58BD5-41BC-4E1B-9C11-CF645E4D0235Q28972388-C5CB2565-F0D2-4645-ADA2-4804D5D2001AQ28972478-993DAAA6-389C-489B-972A-0B9907DEA9F9Q30395243-454804B7-184F-4336-B0BA-C8BC07F00950Q30435819-11813D1E-BB6E-4982-97EF-BD02A8CCB458Q30469126-18119FB9-1C44-48BB-BD6D-D11AC78946D6Q30482891-2BA3E1FD-420D-4BD4-A876-54D6953071FBQ33956664-CFF61AA0-64F4-4EF4-A60E-ACDE93007349Q33966358-6527AD14-C86A-4626-82B3-F4BB29EFD8C9Q34120073-42A24C8E-11AD-4278-A219-124D0347481BQ34120089-02A2BE37-E0A3-4E18-B86A-B06771D0E667Q34224224-BA32BEB5-C6EB-41BA-996A-2EA85C6811D8Q34259426-D497AB10-28D6-479A-B3E0-AF31CBD8086AQ34423658-EF670A2C-189F-4133-ABED-53D0B317DDA2Q34524415-F78F44E4-2F5E-4F00-8E78-47606C9AAD5BQ34566420-03A88A40-C7BD-4331-8037-5D4AF54FD3D9Q34634305-DCE68E69-3E2A-460D-8D6C-DD8E6C9A5172Q35014965-D783FF09-D2A2-4E45-9671-26391CB2EE72Q35147283-60142D4F-98E5-4065-BD51-DB39BA2C95D4Q35309965-AAC04A99-2F0C-4D6E-B6BD-CEBD9BF68EAFQ35650558-88E8BD81-A49F-4B91-AF97-FA36BA8D629EQ36074984-A79A72B2-122E-4C8E-B824-F896775B4468Q36332445-694C985B-4CC7-4EC7-BFFD-75332F46A1CBQ36906661-F74413AD-E916-4FBB-8373-80F17A445B5AQ36922121-D2FDE5EA-7512-4169-B738-A33317BC54A2Q36968906-6B0BB3B8-E546-4EDB-A7D9-415062D6B026Q37031574-BBB2B6B2-4C73-490A-A245-BF6C779891D5Q37138385-3F00EDBE-303A-4629-B041-F625FC8E118EQ37660848-9913270E-5B5B-4FD7-8982-F21C69303982Q37729903-3E0368B4-A7AE-4791-84EF-FB14B6A95346Q37820187-15A22BE2-D98B-4325-8EF4-505B356B1250Q37845661-48670EB6-6123-4503-A894-F4CC3881E407Q37867282-33499108-FACE-467F-AEBA-E8531FD7CE4AQ37992506-0AE46DB4-4C3B-4971-8097-4A2F27205054Q40482829-C47BA8FF-CB86-42E3-903B-C8551B0FF120Q41025805-B12F60E2-DEF3-49C5-A841-5D10D1466BE8Q41162342-2ACD0DC6-796C-4660-B080-67F1725EAE64
P2860
Clonidine treatment of Gilles de la Tourette's syndrome.
description
1991 nî lūn-bûn
@nan
1991 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Clonidine treatment of Gilles de la Tourette's syndrome.
@ast
Clonidine treatment of Gilles de la Tourette's syndrome.
@en
Clonidine treatment of Gilles de la Tourette's syndrome.
@nl
type
label
Clonidine treatment of Gilles de la Tourette's syndrome.
@ast
Clonidine treatment of Gilles de la Tourette's syndrome.
@en
Clonidine treatment of Gilles de la Tourette's syndrome.
@nl
prefLabel
Clonidine treatment of Gilles de la Tourette's syndrome.
@ast
Clonidine treatment of Gilles de la Tourette's syndrome.
@en
Clonidine treatment of Gilles de la Tourette's syndrome.
@nl
P2093
P1433
P1476
Clonidine treatment of Gilles de la Tourette's syndrome.
@en
P2093
P304
P356
10.1001/ARCHPSYC.1991.01810280040006
P407
P577
1991-04-01T00:00:00Z